This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ASM journals
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ashley, R L
Right arrow Articles by Corey, L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ashley, R L
Right arrow Articles by Corey, L

 Previous Article  |  Next Article 

J Clin Microbiol. 1988 April; 26(4): 662-667

Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera.

R L Ashley, J Militoni, F Lee, A Nahmias and L Corey

Department of Laboratory Medicine, University of Washington, Seattle 98105.

ABSTRACT

Sera from patients with culture-proven genital herpes infections were tested for herpes simplex virus type 1 (HSV-1)- and HSV-2-specific antibodies by both a Western blot (immunoblot) technique (WBA) and immunodot enzyme assays (IEAs) specific for HSV-1 or HSV-2 glycoprotein G (gG). Of 137 serum samples tested, none was mistyped by either WBA or IEA. Both tests were most sensitive with sera obtained at least 21 days after onset of primary HSV-2 infections or sera drawn during recurrent HSV-2 genital episodes: 75 of 76 (99%) such serum samples were positive for HSV-2 antibody by WBA and 73 of 76 (96%) were positive by IEA. Of sera drawn earlier than 21 days from onset of primary genital HSV-2, antibodies to HSV-2 were detected in 25% by WBA and 8% by IEA. In patients with culture-proven primary genital HSV-1 infection, WBA detected antibodies to HSV-1 proteins in 16 of 17 (94%) serum samples drawn at least 21 days after onset of primary genital HSV-1 infection, compared with 9 of 17 (53%) serum samples tested for gG-1 by IEA. Both WBA and IEA are accurate and sensitive tests for HSV-2 antibody in patients convalescing from a first episode or having symptomatic or asymptomatic recurrent genital herpes. WBA was more sensitive than IEA in detecting seroconversion following primary HSV-1 genital herpes, although both assays may miss persons undergoing early seroconversion to HSV-2.


J Clin Microbiol. 1988 April; 26(4): 662-667




This article has been cited by other articles:

  • Neal, J. D., Tobian, A. A. R., Laeyendecker, O., Ngo, T. D., Redd, A. D., Reynolds, S. J., Morrow, R. A., Manucci, J. L., Serwadda, D., Gray, R. H., Quinn, T. C. (2011). Performance of the Euroline Western blot assay in the detection of herpes simplex virus type 2 antibody in Uganda, China and the USA. Int J STD AIDS 22: 342-344 [Abstract] [Full Text]  
  • Tronstein, E., Johnston, C., Huang, M.-L., Selke, S., Magaret, A., Warren, T., Corey, L., Wald, A. (2011). Genital Shedding of Herpes Simplex Virus Among Symptomatic and Asymptomatic Persons With HSV-2 Infection. JAMA 305: 1441-1449 [Abstract] [Full Text]  
  • Baeten, J. M., Kahle, E., Lingappa, J. R., Coombs, R. W., Delany-Moretlwe, S., Nakku-Joloba, E., Mugo, N. R., Wald, A., Corey, L., Donnell, D., Campbell, M. S., Mullins, J. I., Celum, C. (2011). Genital HIV-1 RNA Predicts Risk of Heterosexual HIV-1 Transmission. Sci Transl Med 3: 77ra29-77ra29 [Abstract] [Full Text]  
  • Mujugira, A., Morrow, R. A., Celum, C., Lingappa, J., Delany-Moretlwe, S., Fife, K. H., Heffron, R., De Bruyn, G., Homawoo, B., Karita, E., Mugo, N., Vwalika, B., Baeten, J. M., for the Partners in Prevention HSV/HIV Transmissio, (2011). Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countries. Sex. Transm. Infect. 87: 238-241 [Abstract] [Full Text]  
  • Phipps, W., Saracino, M., Magaret, A., Selke, S., Remington, M., Huang, M.-L., Warren, T., Casper, C., Corey, L., Wald, A. (2011). Persistent Genital Herpes Simplex Virus-2 Shedding Years Following the First Clinical Episode. The Journal of Infectious Disease 203: 180-187 [Abstract] [Full Text]  
  • Kwena, Z. A., Bukusi, E. A., Ng'ayo, M. O., Buffardi, A. L., Nguti, R., Richardson, B., Sang, N. M., Holmes, K. (2010). Prevalence and risk factors for sexually transmitted infections in a high-risk occupational group: the case of fishermen along Lake Victoria in Kisumu, Kenya. Int J STD AIDS 21: 708-713 [Abstract] [Full Text]  
  • Lingappa, J., Nakku-Joloba, E., Magaret, A., Friedrich, D., Dragavon, J., Kambugu, F., Joloba, M., Whalen, C., Coombs, R., Celum, C., Morrow, R. A. (2010). Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban Ugandans. Int J STD AIDS 21: 611-616 [Abstract] [Full Text]  
  • Koelle, D. M., Magaret, A., Warren, T., Schellenberg, G. D., Wald, A. (2010). APOE genotype is associated with oral herpetic lesions but not genital or oral herpes simplex virus shedding. Sex. Transm. Infect. 86: 202-206 [Abstract] [Full Text]  
  • Dong, L., Li, P., Oenema, T., McClurkan, C. L., Koelle, D. M. (2010). Public TCR Use by Herpes Simplex Virus-2-Specific Human CD8 CTLs. J. Immunol. 184: 3063-3071 [Abstract] [Full Text]  
  • Tata, S., Johnston, C., Huang, M.-L., Selke, S., Magaret, A., Corey, L., Wald, A. (2010). Overlapping reactivations of herpes simplex virus type 2 in the genital and perianal mucosa. The Journal of Infectious Disease 201: 499-504 [Abstract] [Full Text]  
  • Binnicker, M. J., Jespersen, D. J., Harring, J. A. (2010). Evaluation of Three Multiplex Flow Immunoassays Compared to an Enzyme Immunoassay for the Detection and Differentiation of IgG Class Antibodies to Herpes Simplex Virus Types 1 and 2. CVI 17: 253-257 [Abstract] [Full Text]  
  • Delany-Moretlwe, S., Jentsch, U., Weiss, H., Moyes, J., Ashley-Morrow, R., Stevens, W., Mayaud, P. (2010). Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population. Sex. Transm. Infect. 86: 46-50 [Abstract] [Full Text]  
  • Liu, Y., Woodward, A., Zhu, H., Andrus, T., McNevin, J., Lee, J., Mullins, J. I., Corey, L., McElrath, M. J., Zhu, T. (2009). Preinfection Human Immunodeficiency Virus (HIV)-Specific Cytotoxic T Lymphocytes Failed To Prevent HIV Type 1 Infection from Strains Genetically Unrelated to Viruses in Long-Term Exposed Partners. J. Virol. 83: 10821-10829 [Abstract] [Full Text]  
  • Magaret, A S, Johnston, C, Wald, A (2009). Use of the designation "shedder" in mucosal detection of herpes simplex virus DNA involving repeated sampling. Sex. Transm. Infect. 85: 270-275 [Abstract] [Full Text]  
  • Al-Sulaiman, A. M., Vallely, P. J., Klapper, P. E. (2009). Comparative Performance of a Novel Herpes Simplex Virus Type 2-Specific Enzyme-Linked Immunosorbent Assay Using a Targeted Chain Oligopeptide, Peptide 55. CVI 16: 931-934 [Abstract] [Full Text]  
  • Muller, W. J., Dong, L., Vilalta, A., Byrd, B., Wilhelm, K. M., McClurkan, C. L., Margalith, M., Liu, C., Kaslow, D., Sidney, J., Sette, A., Koelle, D. M. (2009). Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infection. J. Gen. Virol. 90: 1153-1163 [Abstract] [Full Text]  
  • Suntoke, T R, Hardick, A, Tobian, A A R, Mpoza, B, Laeyendecker, O, Serwadda, D, Opendi, P, Gaydos, C A, Gray, R H, Wawer, M J, Quinn, T C, Reynolds, S J (2009). Evaluation of multiplex real-time PCR for detection of Haemophilus ducreyi, Treponema pallidum, herpes simplex virus type 1 and 2 in the diagnosis of genital ulcer disease in the Rakai District, Uganda. Sex. Transm. Infect. 85: 97-101 [Abstract] [Full Text]  
  • Burbelo, P. D., Hoshino, Y., Leahy, H., Krogmann, T., Hornung, R. L., Iadarola, M. J., Cohen, J. I. (2009). Serological Diagnosis of Human Herpes Simplex Virus Type 1 and 2 Infections by Luciferase Immunoprecipitation System Assay. CVI 16: 366-371 [Abstract] [Full Text]  
  • Martins, T. B., Welch, R. J., Hill, H. R., Litwin, C. M. (2009). Comparison of a Multiplexed Herpes Simplex Virus Type-Specific Immunoglobulin G Serology Assay to Immunoblot, Western Blot, and Enzyme-Linked Immunosorbent Assays. CVI 16: 55-60 [Abstract] [Full Text]  
  • Cattamanchi, A., Posavad, C. M., Wald, A., Baine, Y., Moses, J., Higgins, T. J., Ginsberg, R., Ciccarelli, R., Corey, L., Koelle, D. M. (2008). Phase I Study of a Herpes Simplex Virus Type 2 (HSV-2) DNA Vaccine Administered to Healthy, HSV-2-Seronegative Adults by a Needle-Free Injection System. CVI 15: 1638-1643 [Abstract] [Full Text]  
  • Mark, K. E., Wald, A., Magaret, A. S., Selke, S., Olin, L., Huang, M.-L., Corey, L. (2008). Rapidly Cleared Episodes of Herpes Simplex Virus Reactivation in Immunocompetent Adults. The Journal of Infectious Disease 198: 1141-1149 [Abstract] [Full Text]  
  • Tang, S., Bertke, A. S., Patel, A., Wang, K., Cohen, J. I., Krause, P. R. (2008). An acutely and latently expressed herpes simplex virus 2 viral microRNA inhibits expression of ICP34.5, a viral neurovirulence factor. Proc. Natl. Acad. Sci. USA 105: 10931-10936 [Abstract] [Full Text]  
  • Ngo, T. D., Laeyendecker, O., Morrow, R. A., Lai, S., Quinn, T. C. (2008). Comparison of Three Commercial Immunoassays for Detection of Herpes Simplex Virus Type 2 Antibodies in Commercial Sex Workers in Yunnan Province, China. CVI 15: 1301-1303 [Abstract] [Full Text]  
  • Jing, L., Davies, D. H., Chong, T. M., Chun, S., McClurkan, C. L., Huang, J., Story, B. T., Molina, D. M., Hirst, S., Felgner, P. L., Koelle, D. M. (2008). An Extremely Diverse CD4 Response to Vaccinia Virus in Humans Is Revealed by Proteome-Wide T-Cell Profiling. J. Virol. 82: 7120-7134 [Abstract] [Full Text]  
  • Johnston, C., Magaret, A., Selke, S., Remington, M., Corey, L., Wald, A. (2008). Herpes Simplex Virus Viremia during Primary Genital Infection. The Journal of Infectious Disease 198: 31-34 [Abstract] [Full Text]  
  • Gamiel, J. L., Tobian, A. A. R., Laeyendecker, O. B., Reynolds, S. J., Morrow, R. A., Serwadda, D., Gray, R. H., Quinn, T. C. (2008). Improved Performance of Enzyme-Linked Immunosorbent Assays and the Effect of Human Immunodeficiency Virus Coinfection on the Serologic Detection of Herpes Simplex Virus Type 2 in Rakai, Uganda. CVI 15: 888-890 [Abstract] [Full Text]  
  • Koelle, D. M., Magaret, A., McClurkan, C. L., Remington, M. L., Warren, T., Teofilovici, F., Wald, A. (2008). Phase I Dose-Escalation Study of a Monovalent Heat Shock Protein 70-Herpes Simplex Virus Type 2 (HSV-2) Peptide-Based Vaccine Designed To Prime or Boost CD8 T-Cell Responses in HSV-Naive and HSV-2-Infected Subjects. CVI 15: 773-782 [Abstract] [Full Text]  
  • Fujima, A., Ochiai, Y., Saito, A., Omori, Y., Noda, A., Kazuyama, Y., Shoji, H., Tanabayashi, K., Ueda, F., Yoshikawa, Y., Hondo, R. (2008). Discrimination of Antibody to Herpes B Virus from Antibody to Herpes Simplex Virus Types 1 and 2 in Human and Macaque Sera. J. Clin. Microbiol. 46: 56-61 [Abstract] [Full Text]  
  • Summerton, J., Riedesel, M., Laeyendecker, O., Gaydos, C., Maldeis, N. E., Hardick, A., Morrow, R. A., Quinn, T. C. (2007). Effect of Sexually Transmitted Disease (STD) Coinfections on Performance of Three Commercially Available Immunosorbent Assays Used for Detection of Herpes Simplex Virus Type 2-Specific Antibody in Men Attending Baltimore, Maryland, STD Clinics. CVI 14: 1545-1549 [Abstract] [Full Text]  
  • Zuckerman, R. A., Lucchetti, A., Whittington, W. L. H., Sanchez, J., Coombs, R. W., Zuniga, R., Magaret, A. S., Wald, A., Corey, L., Celum, C. (2007). Herpes Simplex Virus (HSV) Suppression with Valacyclovir Reduces Rectal and Blood Plasma HIV-1 Levels in HIV-1/HSV-2-Seropositive Men: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial. The Journal of Infectious Disease 196: 1500-1508 [Abstract] [Full Text]  
  • Mark, K. E., Corey, L., Meng, T.-C., Magaret, A. S., Huang, M.-L., Selke, S., Slade, H. B., Tyring, S. K., Warren, T., Sacks, S. L., Leone, P., Bergland, V. A., Wald, A. (2007). Topical Resiquimod 0.01% Gel Decreases Herpes Simplex Virus Type 2 Genital Shedding: A Randomized, Controlled Trial. The Journal of Infectious Disease 195: 1324-1331 [Abstract] [Full Text]  
  • Ronald, A, Kuypers, J, Lukehart, S A, Peeling, R W, Pope, V (2006). Excellence in sexually transmitted infection (STI) diagnostics: recognition of past successes and strategies for the future. Sex. Transm. Infect. 82: v47-v52 [Abstract] [Full Text]  
  • Brown, E. L., Wald, A., Hughes, J. P., Morrow, R. A., Krantz, E., Mayer, K., Buchbinder, S., Koblin, B., Celum, C. (2006). High Risk of Human Immunodeficiency Virus in Men Who Have Sex with Men with Herpes Simplex Virus Type 2 in the EXPLORE Study. Am J Epidemiol 164: 733-741 [Abstract] [Full Text]  
  • Xu, F., Sternberg, M. R., Kottiri, B. J., McQuillan, G. M., Lee, F. K., Nahmias, A. J., Berman, S. M., Markowitz, L. E. (2006). Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.. JAMA 296: 964-973 [Abstract] [Full Text]  
  • Kim, H. N., Meier, A., Huang, M.-L., Kuntz, S., Selke, S., Celum, C., Corey, L., Wald, A. (2006). Oral Herpes Simplex Virus Type 2 Reactivation in HIV-Positive and -Negative Men. The Journal of Infectious Disease 194: 420-427 [Abstract] [Full Text]  
  • Kasubi, M. J., Nilsen, A., Marsden, H. S., Bergstrom, T., Langeland, N., Haarr, L. (2006). Prevalence of Antibodies against Herpes Simplex Virus Types 1 and 2 in Children and Young People in an Urban Region in Tanzania. J. Clin. Microbiol. 44: 2801-2807 [Abstract] [Full Text]  
  • Martin, E. T., Koelle, D. M., Byrd, B., Huang, M.-L., Vieira, J., Corey, L., Wald, A. (2006). Sequence-Based Methods for Identifying Epidemiologically Linked Herpes Simplex Virus Type 2 Strains. J. Clin. Microbiol. 44: 2541-2546 [Abstract] [Full Text]  
  • Wald, A., Krantz, E., Selke, S., Lairson, E., Morrow, R. A., Zeh, J. (2006). Knowledge of Partners' Genital Herpes Protects against Herpes Simplex Virus Type 2 Acquisition. The Journal of Infectious Disease 194: 42-52 [Abstract] [Full Text]  
  • Gorander, S., Mbwana, J., Lyamuya, E., Lagergard, T., Liljeqvist, J.-A. (2006). Mature Glycoprotein G Presents High Performance in Diagnosing Herpes Simplex Virus Type 2 Infection in Sera of Different Tanzanian Cohorts. CVI 13: 633-639 [Abstract] [Full Text]  
  • Hosken, N., McGowan, P., Meier, A., Koelle, D. M., Sleath, P., Wagener, F., Elliott, M., Grabstein, K., Posavad, C., Corey, L. (2006). Diversity of the CD8+ T-Cell Response to Herpes Simplex Virus Type 2 Proteins among Persons with Genital Herpes. J. Virol. 80: 5509-5515 [Abstract] [Full Text]  
  • Castellsague, X., Diaz, M., de Sanjose, S., Munoz, N., Herrero, R., Franceschi, S., Peeling, R. W., Ashley, R., Smith, J. S., Snijders, P. J. F., Meijer, C. J. L. M., Bosch, F. X. (2006). Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.. JNCI J Natl Cancer Inst 98: 303-315 [Abstract] [Full Text]  
  • Wang, K., Lau, T. Y., Morales, M., Mont, E. K., Straus, S. E. (2005). Laser-Capture Microdissection: Refining Estimates of the Quantity and Distribution of Latent Herpes Simplex Virus 1 and Varicella-Zoster Virus DNA in Human Trigeminal Ganglia at the Single-Cell Level. J. Virol. 79: 14079-14087 [Abstract] [Full Text]  
  • Wald, A., Langenberg, A. G.M., Krantz, E., Douglas, J. M. Jr, Handsfield, H. H., DiCarlo, R. P., Adimora, A. A., Izu, A. E., Morrow, R. A., Corey, L. (2005). The Relationship between Condom Use and Herpes Simplex Virus Acquisition. ANN INTERN MED 143: 707-713 [Abstract] [Full Text]  
  • Bernstein, D. I., Spruance, S. L., Arora, S. S., Schroeder, J. L., Meng, T.-C. (2005). Evaluation of Imiquimod 5% Cream to Modify the Natural History of Herpes Labialis: A Pilot Study. Clinical Infectious Diseases 41: 808-814 [Abstract] [Full Text]  
  • Meyer, J L, Crosby, R A, Whittington, W L H, Carrell, D, Ashley-Morrow, R, Meier, A S, Harrington, R D, DiClemente, R, Wald, A (2005). The psychosocial impact of serological herpes simplex type 2 testing in an urban HIV clinic. Sex. Transm. Infect. 81: 309-315 [Abstract] [Full Text]  
  • Diaz, G. A., Rakita, R. M., Koelle, D. M. (2005). A Case of Ramsay Hunt-Like Syndrome Caused by Herpes Simplex Virus Type 2. Clinical Infectious Diseases 40: 1545-1547 [Abstract] [Full Text]  
  • Perelygina, L., Patrusheva, I., Hombaiah, S., Zurkuhlen, H., Wildes, M. J., Patrushev, N., Hilliard, J. (2005). Production of Herpes B Virus Recombinant Glycoproteins and Evaluation of Their Diagnostic Potential. J. Clin. Microbiol. 43: 620-628 [Abstract] [Full Text]  
  • Gonzalez, J. C., Kwok, W. W., Wald, A., McClurkan, C. L., Huang, J., Koelle, D. M. (2005). Expression of Cutaneous Lymphocyte--Associated Antigen and E-selectin Ligand by Circulating Human Memory CD4+ T Lymphocytes Specific for Herpes Simplex Virus Type 2. The Journal of Infectious Disease 191: 243-254 [Abstract] [Full Text]  
  • Stanberry, L. R., Rosenthal, S. L., Mills, L., Succop, P. A., Biro, F. M., Morrow, R. A., Bernstein, D. I. (2004). Longitudinal Risk of Herpes Simplex Virus (HSV) Type 1, HSV Type 2, and Cytomegalovirus Infections among Young Adolescent Girls. Clinical Infectious Diseases 39: 1433-1438 [Abstract] [Full Text]  
  • Gupta, R., Wald, A., Krantz, E., Selke, S., Warren, T., Vargas-Cortes, M., Miller, G., Corey, L. (2004). Valacyclovir and Acyclovir for Suppression of Shedding of Herpes Simplex Virus in the Genital Tract. The Journal of Infectious Disease 190: 1374-1381 [Abstract] [Full Text]  
  • Wald, A, Ericsson, M, Krantz, E, Selke, S, Corey, L (2004). Oral shedding of herpes simplex virus type 2. Sex. Transm. Infect. 80: 272-276 [Abstract] [Full Text]  
  • Van Dyck, E., Buve, A., Weiss, H. A., Glynn, J. R., Brown, D. W. G., De Deken, B., Parry, J., Hayes, R. J. (2004). Performance of Commercially Available Enzyme Immunoassays for Detection of Antibodies against Herpes Simplex Virus Type 2 in African Populations. J. Clin. Microbiol. 42: 2961-2965 [Abstract] [Full Text]  
  • Laeyendecker, O., Henson, C., Gray, R. H., Nguyen, R. H.-N., Horne, B. J., Wawer, M. J., Serwadda, D., Kiwanuka, N., Morrow, R. A., Hogrefe, W., Quinn, T. C. (2004). Performance of a Commercial, Type-Specific Enzyme-Linked Immunosorbent Assay for Detection of Herpes Simplex Virus Type 2-Specific Antibodies in Ugandans. J. Clin. Microbiol. 42: 1794-1796 [Abstract] [Full Text]  
  • Song, B, Dwyer, D E, Mindel, A (2004). HSV type specific serology in sexual health clinics: use, benefits, and who gets tested. Sex. Transm. Infect. 80: 113-117 [Abstract] [Full Text]  
  • Gray, R. H., Li, X., Wawer, M. J., Serwadda, D., Sewankambo, N. K., Mangen, F. W., Lutalo, T., Kiwanuka, N., Kigozi, G., Nalugoda, F., Meehan, M. P., Robb, M., Quinn, T. C. (2004). Determinants of HIV-1 Load in Subjects with Early and Later HIV Infections, in a General-Population Cohort of Rakai, Uganda. The Journal of Infectious Disease 189: 1209-1215 [Abstract] [Full Text]  
  • Morrow, R. A., Friedrich, D., Krantz, E. (2003). Performance of the Focus and Kalon Enzyme-Linked Immunosorbent Assays for Antibodies to Herpes Simplex Virus Type 2 Glycoprotein G in Culture-Documented Cases of Genital Herpes. J. Clin. Microbiol. 41: 5212-5214 [Abstract] [Full Text]  
  • Wald, A., Huang, M.-L., Carrell, D., Selke, S., Corey, L. (2003). Polymerase Chain Reaction for Detection of Herpes Simplex Virus (HSV) DNA on Mucosal Surfaces: Comparison with HSV Isolation in Cell Culture. The Journal of Infectious Disease 188: 1345-1351 [Abstract] [Full Text]  
  • Koelle, D. M., Liu, Z., McClurkan, C. L., Cevallos, R. C., Vieira, J., Hosken, N. A., Meseda, C. A., Snow, D. C., Wald, A., Corey, L. (2003). Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor. Proc. Natl. Acad. Sci. USA 100: 12899-12904 [Abstract] [Full Text]  
  • Gorander, S., Svennerholm, B., Liljeqvist, J.-A. (2003). Secreted Portion of Glycoprotein G of Herpes Simplex Virus Type 2 Is a Novel Antigen for Type-Discriminating Serology. J. Clin. Microbiol. 41: 3681-3686 [Abstract] [Full Text]  
  • Cherpes, T. L., Meyn, L. A., Krohn, M. A., Lurie, J. G., Hillier, S. L. (2003). Association between Acquisition of Herpes Simplex Virus Type 2 in Women and Bacterial Vaginosis. Clinical Infectious Diseases 37: 319-325 [Abstract] [Full Text]  
  • Page, J, Taylor, J, Tideman, R L, Seifert, C, Marks, C, Cunningham, A, Mindel, A (2003). Is HSV serology useful for the management of first episode genital herpes?. Sex. Transm. Infect. 79: 276-279 [Abstract] [Full Text]  
  • Melville, J, Sniffen, S, Crosby, R, Salazar, L, Whittington, W, Dithmer-Schreck, D, DiClemente, R, Wald, A (2003). Psychosocial impact of serological diagnosis of herpes simplex virus type 2: a qualitative assessment. Sex. Transm. Infect. 79: 280-285 [Abstract] [Full Text]  
  • Posavad, C. M., Wald, A., Hosken, N., Huang, M. L., Koelle, D. M., Ashley, R. L., Corey, L. (2003). T Cell Immunity to Herpes Simplex Viruses in Seronegative Subjects: Silent Infection or Acquired Immunity?. J. Immunol. 170: 4380-4388 [Abstract] [Full Text]  
  • Nichols, W. G., Boeckh, M., Carter, R. A., Wald, A., Corey, L. (2003). Transferred Herpes Simplex Virus Immunity after Stem-Cell Transplantation: Clinical Implications. The Journal of Infectious Disease 187: 801-808 [Abstract] [Full Text]  
  • Cherpes, T. L., Ashley, R. L., Meyn, L. A, Hillier, S. L. (2003). Longitudinal Reliability of Focus Glycoprotein G-Based Type-Specific Enzyme Immunoassays for Detection of Herpes Simplex Virus Types 1 and 2 in Women. J. Clin. Microbiol. 41: 671-674 [Abstract] [Full Text]  
  • Fisman, D N, Hook, E W III, Goldie, S J (2003). Estimating the costs and benefits of screening monogamous, heterosexual couples for unrecognised infection with herpes simplex virus type 2. Sex. Transm. Infect. 79: 45-52 [Abstract] [Full Text]  
  • Brown, Z. A., Wald, A., Morrow, R. A., Selke, S., Zeh, J., Corey, L. (2003). Effect of Serologic Status and Cesarean Delivery on Transmission Rates of Herpes Simplex Virus From Mother to Infant. JAMA 289: 203-209 [Abstract] [Full Text]  
  • Koelle, D. M., Corey, L. (2003). Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research. Clin. Microbiol. Rev. 16: 96-113 [Abstract] [Full Text]  
  • Renzi, C., Douglas, J. M. Jr., Foster, M., Critchlow, C. W., Ashley-Morrow, R., Buchbinder, S. P., Koblin, B. A., McKirnan, D. J., Mayer, K. H., Celum, C. L. (2003). Herpes Simplex Virus Type 2 Infection as a Risk Factor for Human Immunodeficiency Virus Acquisition in Men Who Have Sex with Men. The Journal of Infectious Disease 187: 19-25 [Abstract] [Full Text]  
  • Smith, J. S., Herrero, R., Bosetti, C., Munoz, N., Bosch, F. X., Eluf-Neto, J., Castellsague, X., Meijer, C. J. L. M., Van den Brule, A. J. C., Franceschi, S., Ashley, R. (2002). Herpes Simplex Virus-2 as a Human Papillomavirus Cofactor in the Etiology of Invasive Cervical Cancer. JNCI J Natl Cancer Inst 94: 1604-1613 [Abstract] [Full Text]  
  • Wald, A., Ashley-Morrow, R. (2002). Serological Testing for Herpes Simplex Virus (HSV)-1 and HSV-2 Infection. Clinical Infectious Diseases 35: S173-S182 [Abstract] [Full Text]  
  • Corey, L. (2002). Challenges in Genital Herpes Simplex Virus Management. The Journal of Infectious Disease 186: S29-S33 [Abstract] [Full Text]  
  • Wald, A., Zeh, J., Selke, S., Warren, T., Ashley, R., Corey, L. (2002). Genital Shedding of Herpes Simplex Virus among Men. The Journal of Infectious Disease 186: S34-S39 [Abstract] [Full Text]  
  • Schacker, T. W., Conant, M., Thoming, C., Stanczak, T., Wang, Z., Smith, M. (2002). Imiquimod 5-Percent Cream Does Not Alter the Natural History of Recurrent Herpes Genitalis: a Phase II, Randomized, Double-Blind, Placebo-Controlled Study. Antimicrob. Agents Chemother. 46: 3243-3248 [Abstract] [Full Text]  
  • Hogrefe, W., Su, X., Song, J., Ashley, R., Kong, L. (2002). Detection of Herpes Simplex Virus Type 2-Specific Immunoglobulin G Antibodies in African Sera by Using Recombinant gG2, Western Blotting, and gG2 Inhibition. J. Clin. Microbiol. 40: 3635-3640 [Abstract] [Full Text]  
  • Cowan, F M, Copas, A, Johnson, A M, Ashley, R, Corey, L, Mindel, A (2002). Herpes simplex virus type 1 infection: a sexually transmitted infection of adolescence?. Sex. Transm. Infect. 78: 346-348 [Abstract] [Full Text]  
  • Leach, C. T., Ashley, R. L., Baillargeon, J., Jenson, H. B. (2002). Performance of Two Commercial Glycoprotein G-Based Enzyme Immunoassays for Detecting Antibodies to Herpes Simplex Viruses 1 and 2 in Children and Young Adolescents. CVI 9: 1124-1125 [Abstract] [Full Text]  
  • Koelle, D. M., Barcy, S., Huang, M.-L., Ashley, R. L., Corey, L., Zeh, J., Ashton, S., Buchwald, D. (2002). Markers of Viral Infection in Monozygotic Twins Discordant for Chronic Fatigue Syndrome. Clinical Infectious Diseases 35: 518-525 [Abstract] [Full Text]  
  • Ikoma, M., Liljeqvist, J.-A., Groen, J., Glazenburg, K. L., The, T. H., Welling-Wester, S. (2002). Use of a Fragment of Glycoprotein G-2 Produced in the Baculovirus Expression System for Detecting Herpes Simplex Virus Type 2-Specific Antibodies. J. Clin. Microbiol. 40: 2526-2532 [Abstract] [Full Text]  
  • Opaneye, A A, Bashford, J (2002). Seroprevalence of antibodies to herpes simplex virus types 1 and 2 among two sexually active female populations in Middlesbrough, England. The Journal of the Royal Society for the Promotion of Health 122: 108-111 [Abstract]  
  • Koelle, D. M., Chen, H. B., McClurkan, C. M., Petersdorf, E. W. (2002). Herpes simplex virus type 2-specific CD8 cytotoxic T lymphocyte cross-reactivity against prevalent HLA class I alleles. Blood 99: 3844-3847 [Abstract] [Full Text]  
  • Anna, W., David, C., Michael, R., Elizabeth, K., Judy, Z., Lawrence, C. (2002). Two-Day Regimen of Acyclovir for Treatment of Recurrent Genital Herpes Simplex Virus Type 2 Infection. Clinical Infectious Diseases 34: 944-948 [Abstract] [Full Text]  
  • Eing, B. R., Lippelt, L., Lorentzen, E. U., Hafezi, W., Schlumberger, W., Steinhagen, K., Kuhn, J. E. (2002). Evaluation of Confirmatory Strategies for Detection of Type-Specific Antibodies against Herpes Simplex Virus Type 2. J. Clin. Microbiol. 40: 407-413 [Abstract] [Full Text]  
  • Liljeqvist, J.-A., Trybala, E., Hoebeke, J., Svennerholm, B., Bergstrom, T. (2002). Monoclonal antibodies and human sera directed to the secreted glycoprotein G of herpes simplex virus type 2 recognize type-specific antigenic determinants. J. Gen. Virol. 83: 157-165 [Abstract] [Full Text]  
  • Wald, A., Link, K. (2002). Risk of Human Immunodeficiency Virus Infection in Herpes Simplex Virus Type 2-Seropositive Persons: A Meta-analysis. The Journal of Infectious Disease 185: 45-52 [Abstract] [Full Text]  
  • Starr, J. R., Daling, J. R., Fitzgibbons, E. D., Madeleine, M. M., Ashley, R., Galloway, D. A., Schwartz, S. M. (2001). Serologic Evidence of Herpes Simplex Virus 1 Infection and Oropharyngeal Cancer Risk. Cancer Res. 61: 8459-8464 [Abstract] [Full Text]  
  • Ashley, R. L (2001). Sorting out the new HSV type specific antibody tests. Sex. Transm. Infect. 77: 232-237 [Abstract] [Full Text]  
  • Wald, A., Langenberg, A. G. M., Link, K., Izu, A. E., Ashley, R., Warren, T., Tyring, S., Douglas, J. M. Jr, Corey, L. (2001). Effect of Condoms on Reducing the Transmission of Herpes Simplex Virus Type 2 From Men to Women. JAMA 285: 3100-3106 [Abstract] [Full Text]  
  • Moscicki, A.-B., Hills, N., Shiboski, S., Powell, K., Jay, N., Hanson, E., Miller, S., Clayton, L., Farhat, S., Broering, J., Darragh, T., Palefsky, J. (2001). Risks for Incident Human Papillomavirus Infection and Low-Grade Squamous Intraepithelial Lesion Development in Young Females. JAMA 285: 2995-3002 [Abstract] [Full Text]  
  • Thomas, D. B., Ray, R. M., Koetsawang, A., Kiviat, N., Kuypers, J., Qin, Q., Ashley, R. L., Koetsawang, S. (2001). Human Papillomaviruses and Cervical Cancer in Bangkok. I. Risk Factors for Invasive Cervical Carcinomas with Human Papillomavirus Types 16 and 18 DNA. Am J Epidemiol 153: 723-731 [Abstract] [Full Text]  
  • Koelle, D. M., Chen, H. B., Gavin, M. A., Wald, A., Kwok, W. W., Corey, L. (2001). CD8 CTL from Genital Herpes Simplex Lesions: Recognition of Viral Tegument and Immediate Early Proteins and Lysis of Infected Cutaneous Cells. J. Immunol. 166: 4049-4058 [Abstract] [Full Text]  
  • Hladik, F., Bender, S., Akridge, R. E., Hu, Y., Galloway, C., Francis, D., McElrath, M. J. (2001). Recombinant HIV-1 Glycoprotein 120 Induces Distinct Types of Delayed Hypersensitivity in Persons With or Without Pre-Existing Immunologic Memory. J. Immunol. 166: 3580-3588 [Abstract] [Full Text]  
  • Liljeqvist, J.-A., Svennerholm, B., Bergstrom, T. (2000). Conservation of Type-Specific B-Cell Epitopes of Glycoprotein G in Clinical Herpes Simplex Virus Type 2 Isolates. J. Clin. Microbiol. 38: 4517-4522 [Abstract] [Full Text]  
  • Koelle, D. M., Reymond, S. N., Chen, H., Kwok, W. W., McClurkan, C., Gyaltsong, T., Petersdorf, E. W., Rotkis, W., Talley, A. R., Harrison, D. A. (2000). Tegument-Specific, Virus-Reactive CD4 T Cells Localize to the Cornea in Herpes Simplex Virus Interstitial Keratitis in Humans. J. Virol. 74: 10930-10938 [Abstract] [Full Text]  
  • Siscovick, D. S., Schwartz, S. M., Corey, L., Grayston, J. T., Ashley, R., Wang, S.-P., Psaty, B. M., Tracy, R. P., Kuller, L. H., Kronmal, R. A. (2000). Chlamydia pneumoniae, Herpes Simplex Virus Type 1, and Cytomegalovirus and Incident Myocardial Infarction and Coronary Heart Disease Death in Older Adults : The Cardiovascular Health Study. Circulation 102: 2335-2340 [Abstract] [Full Text]  
  • Koelle, D. M., Schomogyi, M., Corey, L. (2000). Antigen-Specific T Cells Localize to the Uterine Cervix in Women with Genital Herpes Simplex Virus Type 2 Infection. The Journal of Infectious Disease 182: 662-670 [Abstract] [Full Text]  
  • Van Doornum, G. J. J., Slomka, M. J., Buimer, M., Groen, J., Van den Hoek, J. A. R., Cairo, I., Vyse, A., Brown, D. W. G. (2000). Comparison of a Monoclonal Antibody-Blocking Enzyme-Linked Immunoassay and a Strip Immunoblot Assay for Identifying Type-Specific Herpes Simplex Virus Type 2 Serological Responses. CVI 7: 641-644 [Abstract] [Full Text]